Guangdong Raynovent Biotech Co., Ltd.
Guangdong Raynovent Biotech is a Guangzhou-based developer of metabolic drugs. Its candidate RAY1225 is in Phase 3 in China, with Phase 2 results presented at ADA 2026.
| Headquarters | Guangzhou, China |
|---|---|
| Listing | Not disclosed |
| Lead asset / stage | RAY1225 Phase 3 — China |
| Latest event | Raynovent presented RAY1225 Phase 2 results at ADA 2026. |